Bibliography
- Carracedo J, Ramirez R, Pintado O, Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol 1995;1:1586-91
- Nahar N, Shah H, Siu J, Dialysis membrane-induced neutrophil apoptosis is mediated through free radicals. Clin Nephrol 2001;1:52-9
- Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;4:283-8
- Garcia Moreira V, de la Cera Martinez T, Gago Gonzalez E, Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by Real-Time PCR. Clin Chem Lab Med 2006;12:1410-15
- Steinman CR, Ackad A. Appearance of circulating DNA during hemodialysis. Am J Med 1977;5:693-7
- Fournie GJ, Lule J, Dueymes JM, Plasma DNA in patients undergoing hemodialysis or hemofiltration: cytolysis in artificial kidney is responsible for the release of DNA in circulation. Am J Nephrol 1989;5:384-91
- Rumore P, Muralidhar B, Lin M, Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol 1992;1:56-62
- Atamaniuk J, Ruzicka K, Stuhlmeier KM, Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem 2006;3:523-6
- Korabecna M, Opatrna S, Wirth J, Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann NY Acad Sci 2008;1137:296-301
- Atamaniuk J, Kopecky C, Skoupy S, Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant 2011; published on line 13 December 2011; doi: 10.1093/ndt/gfr695
- Levenson VV. DNA methylation as a universal biomarker. Expert Rev Mol Diagn 2010;4:481-8
- Dworkin AM, Huang TH, Toland AE. Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 2009;3:165-71
- Hoque MO. DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Rev Mol Diagn 2009;3:243-57
- Anglim PP, Alonzo TA, Laird-Offringa IA. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer 2008;7:81-93
- Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009;11:1056-72
- Aspinall R. T cell development, ageing and Interleukin-7. Mech Ageing Dev 2006;127:572-8
- Cooper AC, Mikhail A, Lethbridge MW, Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 2003;7:1776-84
- Chung BH, Kim KW, Sun IO, Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett 2012;2:181-9
- Vogl C, Flatt T, Fuhrmann B, Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes. BMC Genomics 2010;11:199-217
- Son GH, Chung S, Kim K. The adrenal peripheral clock: glucocorticoid and the circadian timing system. Front Neuroendocrinol 2011;32:451-65
- Korabecna M, Horinek A. Cell-free nucleic acids as biomarkers of biocompatibility in dialytic process. In: Penido MG, editor. Technical Problems in Patients on Hemodialysis. InTech. Rijeka; Croatia: 2011
- Woroniecka KI, Park AS, Mohtat D, Transcriptome analysis of human diabetic kidney disease. Diabetes 2011;9:2354-69
- Sapienza C, Lee J, Powell J, DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. 2011;1:20-8
- Jain S, De Petris L, Hoshi M, Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. Lab Invest 2011;4:488-98